Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Production & Manufacturing
Fine & Speciality Chemicals
Return to: PBR Home | Production & Manufacturing | Fine & Speciality Chemicals

Fine & Speciality Chemicals

Bayer plans to focus entirely on Life Science businesses Bayer intends in the future to focus entirely on the Life Science businesses – HealthCare and CropScience – and float MaterialScience on the stock market as a separate company. In this way Bayer is positioning itself as a world-leading company in the field of human, animal and plant health.
Production & Manufacturing > Fine & Speciality Chemicals > News
CordenPharma agrees to purchase Peptisyntha from Solvay By PBR Staff Writer
International Chemical Investors Group (ICIG) and the Solvay Group have embarked on an agreement, whereby ICIG will purchase Belgium-based Peptisyntha SA, a custom manufacturer of peptides for pharmaceutical use.
Production & Manufacturing > Fine & Speciality Chemicals > News INVISTA, SilicoLife to develop new technologies for bio-derived processes By PBR Staff Writer
INVISTA and SilicoLife, a computational biology company, have collaborated to develop new technologies that facilitate bio-derived processes for the production of industrial chemicals.
Production & Manufacturing > Fine & Speciality Chemicals > News
See more Fine & Speciality Chemicals news

Latest Fine & Speciality Chemicals News and Insight

View all Fine & Speciality Chemicals news or find news targeted to your interests
Milled Lactose – For Optimum Granulation
GranuLac® and SorboLac®, milled lactose, have good compaction properties due to its small particle size. It is best granulated, wet or dry, before tablet production. It is the most frequently used excipient for granulation.
Production & Manufacturing > Fine & Speciality Chemicals > Products
Sieved Lactose – With Superior Blending Properties
Lactose is sieve-fractionated into various grades with a narrow particle size distribution and exhibits good flow. Sieved lactose consists of mono-crystals and agglomerates. Our product variety allows your application to be easily optimized. Due to good blending properties and excellent flowability, our products are especially suitable for powder blends, and capsule and sachet filling.
Production & Manufacturing > Fine & Speciality Chemicals > Products
Direct Compression (DC) – Maximum Profitability
Direct compression is the least complex and most cost-effective alternative to traditional granulation. Because they are convenient and easy to administer, tablets are the most popular pharmaceutical dosage form. They can be produced inexpensively in large volumes. Moreover, dosing accuracy is consistent. Given the efficiencies, direct compression is becoming the preferred process for tablet manufacture by pharmaceutical companies globally. Decreased energy, labour, and capital costs as well as the increase in overall product stability are a few of the many benefits.
Production & Manufacturing > Fine & Speciality Chemicals > Products
Lactose for Inhalation Applications – Versatile, in Line With Your Needs
InhaLac® is tightly controlled sieved or milled lactose specifically designed and especially suited for dry powder inhalation drug delivery. InhaLac® products are available in standard forms or as customised solutions to suit your exacting needs. InhaLac® fulfills the need for excellent flowability, defined particle surface, and chemical and physical stability in dry powder inhalation drug delivery.
Production & Manufacturing > Fine & Speciality Chemicals > Products
Contract Manufacturing
MEGGLE is contract manufacturing various products for their customers also. With a broad spectrum of effort and state-of-the- art production equipment, MEGGLE is able to realize customer requirements quickly, reliably, and with the highest technical level.
Production & Manufacturing > Fine & Speciality Chemicals > Products
MEGGLE – Experts in Excipients: The Whole World of Lactose
MEGGLE Excipients & Technology is a global leader in the manufacture of lactose for the pharmaceutical industry. Supporting supply chain security with manufacturing facilities in Europe and North America, MEGGLE offers a broad product portfolio of lactose excipients, co-processed technologies and excipient contract manufacturing.
Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
Novel Co-processed Excipient for Directly Compressed Controlled Release Formulations
| By MEGGLE
A novel excipient comprising 50% lactose monohydrate and 50% hypromellose K4M was prepared via co-processing, integrating the parent materials into a monoparticulate structure offering superior functional performance and simplified processing compared to simple physical admixtures of the same composition. Powder flow, tablet compaction, and wettability showed enhanced performance as a result of excipient co-processing. API dissolution studies with slight compositional modifications and simplified manufacturing method demonstrated flexibility in tablet performance without altering the API release profile.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
MODELING DRUG RELEASE FROM RETALAC® TABLETS: IMPACT OF DRUG SOLUBILITY
| By MEGGLE
Hydrophilic matrices are frequently used to control drug release from oral solid dosage forms. Recently, RetaLac®, a co-processed blend of 50% hydroxypropyl methylcellulose and 50% lactose monohydrate (mechanically inseparable) has been marketed. RetaLac® can be used to prepare matrix tablets by direct compression. However, yet little is known on the underlying drug release mechanisms from this type of dosage forms.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
Co-processed, lactose-based Excipients and their Performance in a First and Second Compaction Process
| By MEGGLE
Dry granulation processes gain growing importance in pharmaceutical industries and the number of excipients used increases steadily.
Production & Manufacturing > Fine & Speciality Chemicals > White Papers
View all Fine & Speciality Chemicals news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250